CD96 and neoplasm: When assessing cell type interactions between CD8+ T cells (marker gene: CD8A) and tumor cells (marker gene: EpCAM) (Fig. 5a), most of them showed interactions known to be mediating immunity, including that of CD155 with CD96 between CD8+ T cells and tumor cells.